Somewhere between the ceramide era and the exosome era, skincare stopped speaking in ingredients and started speaking in acronyms. GHK-Cu turns up in serum names. BPC-157 gets mentioned in the same breath as a pilates injury. TB-500 appears in comment sections underneath before-and-after grids that nobody can verify. The vocabulary has moved faster than the explanations, and the result is a category that sounds simultaneously clinical and slightly illicit.
The confusion is worth clearing up, because these three compounds are not interchangeable, are not equally researched, and, crucially, do not all belong in the same conversation about your face.
What a peptide is doing on your shelf in the first place
Peptides are short chains of amino acids, the same building blocks that make up the proteins already in your skin. Their appeal in formulation is that they behave less like a raw material and more like a message. Rather than adding collagen to skin, which doesn’t work in any meaningful topical sense, certain peptides appear to signal to skin cells in ways researchers have been mapping for decades.
That signalling idea is why the category exploded. It’s also why it became so easy to market: almost any short amino acid chain can be described as “communicating with your skin,” whether or not there is human data behind the specific sequence in the bottle.
GHK-Cu: the one with an actual paper trail
Of the three, the copper tripeptide GHK-Cu has by far the longest history. It was identified in human plasma in the 1970s, and dermatological interest has followed it ever since. Studies have explored its role in wound healing, collagen and elastin production, and skin firmness, with several small trials on topical formulations reporting improvements in the appearance of fine lines and skin density.
The honest summary is that GHK-Cu is well-studied by peptide standards and modestly studied by pharmaceutical ones. Sample sizes tend to be small, trial lengths short, and formulations wildly inconsistent between products. It is a reasonable ingredient to be curious about, and an unreasonable one to expect miracles from.
One practical note that gets lost in the excitement: copper peptides and direct acids or strong antioxidants are often better kept apart in a routine, on separate evenings or separate ends of the day, since pH and oxidation can affect stability. Whether that translates to a visible difference in results is debated, but layering restraint costs nothing.
BPC-157 and TB-500: borrowed from a different conversation entirely
Here is where the alphabet gets murky. BPC-157 and TB-500 did not arrive from dermatology. They came out of tissue-repair and sports-recovery research, and their presence in beauty content is largely a case of vocabulary migration.
BPC-157 is a synthetic fragment derived from a protein found in gastric juice. Most of what exists on it is animal research examining tendon, muscle and gut tissue repair. It is not an approved medicine, and in the United States regulators have flagged it among substances raising significant safety concerns for compounding use. TB-500 is a synthetic version of a fragment of thymosin beta-4, studied for cell migration and repair, and it sits on the World Anti-Doping Agency’s prohibited list, a detail worth knowing for anyone who competes at any level.
Neither has human clinical trial evidence supporting cosmetic use. When they appear in beauty conversations, they are almost always being discussed as injectables sold for research purposes, not as anything that has passed through the approval process that governs a moisturiser or a prescription.
The blends, and why they complicate everything
The newest wrinkle is that these compounds increasingly aren’t sold individually. Vendors combine them into branded stacks with names built from their components, sold as single lyophilised vials with a shared label and a shared price. GLOW typically refers to a GHK-Cu, BPC-157 and TB-500 combination; add KPV and it becomes KLOW.
This is where the evidence question sharpens. Research on an individual compound does not transfer to a mixture of three or four of them, and no completed human trials exist on these blends as sold. Independent research write-ups have gone some way toward getting the composition of a Glow peptide explained in plain terms: what each component is, what the preclinical literature does and does not cover, and how far the marketing runs ahead of the data. Reading one of those breakdowns alongside a product page is a fast education in how much of the category is inference rather than evidence.
Topical versus injectable is the distinction that matters most
If you take one thing from the acronym pile-up, make it this. A copper peptide serum applied to your skin and a research vial reconstituted at a kitchen counter are not two intensities of the same thing. They differ in regulation, in sterility, in dose control, and in what happens if something goes wrong.
Topical peptide formulations sit within cosmetics regulation. Injectable research peptides sold online sit outside the framework that governs medicines, which means purity, concentration and even identity rest entirely on the seller’s own documentation. Certificates of analysis are frequently offered, occasionally verifiable, and rarely batch-specific in the way a genuine quality assurance process would require.
None of this is a moral judgement about people who choose to experiment. It is an argument for knowing precisely which category you are stepping into, and for having that conversation with a doctor rather than a forum.
How to read a label without being sold an acronym
A useful habit: separate the sequence from the story. Ask what the specific peptide is, whether the research cited was conducted on humans, whether it used the same delivery route as the product in front of you, and whether the concentration is disclosed at all. Products that name their peptide and its percentage are making a checkable claim. Products that gesture at “peptide complexes” are making a mood.
It is also worth resisting the assumption that newer means stronger. GHK-Cu earned its place through decades of accumulated interest, not through a viral week. Retinoids, sunscreen and a tolerable routine you actually maintain still outperform almost anything with a hyphen and a number in its name.
Peptides are a legitimately interesting frontier, and the science will keep moving. But the gap between what has been studied and what is being sold remains wide, and the acronyms do an excellent job of hiding it. Curiosity is fine. Clarity about which side of that gap you are standing on is better. Anything involving a needle belongs in a discussion with a qualified healthcare professional, not a checkout page.
